Jianguo Xu

Oct 7, 2024 | jamanetwork.com | Jianguo Xu |Ya Gao |Jinhui Tian |Li Shen

Benefit of RAS Blockade in Heart Failure by Race Li Shen, MBChB, PhD; Matthew M. Y. Lee, MBChB, PhD; Pardeep S. Jhund, MBChB, MSc, PhD; Christopher B. Granger, MD; Inder S. Anand, MD, PhD; Aldo P. Maggioni, MD; Marc A. Pfeffer, MD, PhD; Scott D. Solomon, MD; Karl Swedberg, MD, PhD; Salim Yusuf, DPhil; John J. V. McMurray, MD Evaluating Tools for Assessing Bias in a Meta-Analysis of Clinical Trials on Race and RAS Blockade—Reply Li Shen, MBChB, PhD; Pardeep S. Jhund, MBChB, MSc, PhD; John J. V.

Sep 18, 2023 | dovepress.com | Ruoran Wang |Jianguo Xu

Ruoran Wang,1,* Jing Zhang,1,* Min He,2 Jianguo Xu1 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, People’s Republic of China; 2Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan Province, People’s Republic of China *These authors contributed equally to this work Correspondence: Jianguo Xu, Department of Neurosurgery, West China Hospital, Sichuan University, No. 37, Guoxue Alley,...

Feb 23, 2023 | octnews.org | Jianguo Xu

An Automatic Image Processing Method Based on Artificial Intelligence for Locating the Key Boundary Points in the Central Serous Chorioretinopathy Lesion AreaFebruary 23, 2023 | Ophthalmology | Jinan University, Nanjing University of Aeronautics and Astronautics Accurately and rapidly measuring the diameter of central serous chorioretinopathy (CSCR) lesion area is the key to judge the severity of CSCR and evaluate the efficacy of the corresponding treatments.